{"filing":{"accession_number":"0001588978-26-000028","cik":"0001588978","ticker":"PRCT","company_name":"PROCEPT BioRobotics Corp","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"prct-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1588978/000158897826000028/prct-20260804.htm"},"events":[{"id":24003,"run_id":21712,"accession_number":"0001588978-26-000028","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"PROCEPT BioRobotics issued a press release on August 4, 2026 announcing unaudited financial results for the quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($94.5 million, up 19% YoY), gross margin (66%), net loss ($26.9 million), and full-year 2026 guidance (revenue $390–$410 million, representing 27–33% growth). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.","company_name":"PROCEPT BioRobotics Corp","ticker":"PRCT","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":24382,"accession_number":"0001588978-26-000028","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"PROCEPT BioRobotics issued a press release on August 4, 2026 announcing unaudited financial results for the quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($94.5 million, up 19% YoY), gross margin (66%), net loss ($26.9 million), and full-year 2026 guidance (revenue $390–$410 million, representing 27–33% growth). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:37:43.371417+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24382,"accession_number":"0001588978-26-000028","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"PROCEPT BioRobotics issued a press release on August 4, 2026 announcing unaudited financial results for the quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($94.5 million, up 19% YoY), gross margin (66%), net loss ($26.9 million), and full-year 2026 guidance (revenue $390–$410 million, representing 27–33% growth). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:37:43.371417+00:00","company_name":"PROCEPT BioRobotics Corp","ticker":"PRCT","filing_date":"2026-08-04"}]}